Facebook Twitter YouTube SoundCloud RSS

New York to Prioritize ‘Non-White’ People When Distributing New COVID Treatments

In the latest episode of the Great American Culture Wars, New York’s state government has announced that they will prioritizing non-white people for COVID-19 treatments, apparently due to race-based “longstanding systemic health and social inequities.”

New York Department of Health recently released the document titled: “Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies and Oral Antivirals for the Treatment of COVID-19 During Times of Resource Limitations Introduction,” which outlines the social hierarchy of who will receive monoclonal antibody treatment first, along with new experimental oral antiviral pills like Merck’s molnupiravir and Pfizer’s Paxlovid – both of which were recently waved through by the U.S. Food and Drug Administration (FDA) that last week under Emergency Use Authorization (EUA).

In the document, state officials included a “note” stipulating that any COVID-infected ‘non-white’ persons  should receive priority for treatment over their white counterparts, supposedly because of “inequities” in society.

Restore Your Health - Clive de Carle's Natural Vitamin & Mineral Supplements
Get Clive de Carle's Natural Health essentials of the finest quality, including vitamin & mineral supplements here.

Normally, New York state would prioritize social service benefits based on an individual’s risk factors.  Top priority would normally do to the immunocompromised, people aged 65 or older, and the clinically obese. However, state official have now redefined physical risk factors to include the color of a person’s skin. It now states:

“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19.” 

Fox News reported a statement on the matter by Erin Silk, spokesperson for the New York Department of Health, saying, “Systemic poverty, which has clearly proven to be a risk factor in populations in New York State and nationwide, is added to the algorithm of prioritization similar to all other risk factors. It is merely mentioned as a factor that increases risk.”

The Blaze explains how this new discriminatory directive actually comes by way of Biden’s newly reformed Centers for Disease Control and Prevention (CDC):

The spokesperson noted that the state’s “prioritization guidance comes directly from the CDC,” adding “Race nor ethnicity would disqualify an individual from receiving treatment.”

The Centers for Disease Control and Prevention states, “Race and ethnicity are risk markers for other underlying conditions that affect health, including socioeconomic status, access to health care, and exposure to the virus related to occupation, e.g., frontline, essential, and critical infrastructure workers.”

The New York City Department of Health also recommends that race should be considered when prioritizing who receives monoclonal antibodies and oral antiviral pills for COVID-19.

“Consider race and ethnicity when assessing individual risk, as longstanding systemic health and social inequities may contribute to an increased risk of getting sick and dying from COVID-19,” the memo to providers reads.

READ MORE COVID NEWS AT: 21st Century Wire COVID Files



Get Surfshark - Jaw Dropping Deals on Fast, Easy-to-Use VPN



Get Your Copy of New Dawn Magazine #203 - Mar-Apr Issue
Get Your Copy of New Dawn Magazine #203 - Mar-Apr Issue